UroGen Pharma
URGN • NASDAQ
UroGen Pharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Elizabeth A. Barrett, with a market cap of $999.4M.
Market Cap$999.4M
Employees204.0
CEOElizabeth A. Barrett
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · In 4 weeksQ1 2026
Financials
UroGen Pharma FAQ
Common questions about UroGen Pharma
UroGen Pharma is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $43.8M.
UroGen Pharma has approximately 204 employees.